Search

Your search keyword '"Fouladi M"' showing total 385 results

Search Constraints

Start Over You searched for: Author "Fouladi M" Remove constraint Author: "Fouladi M"
385 results on '"Fouladi M"'

Search Results

1. ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium

2. Prognostic Factors for Pediatric, Adolescent, and Young Adult Patients with Non-DIPG Grade 4 Gliomas: A Contemporary Pooled Institutional Experience

6. Risk of Secondary Malignant Neoplasms in Children Following Proton Therapy vs. Photon Therapy for Primary CNS Tumors

7. Intercontinental collaboration in clinical trials for children and adolescents with cancer—A systematic review by ACCELERATE

9. Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data

11. Title: Defining the clinical and prognostic landscape of embryonal tumors with multi-layered rosettes (ETMRs), a rare brain tumor registry (RBTC) study.

12. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma

13. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA

14. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study

16. Impact of Molecular Subgroups on Outcomes Following Radiation Treatment Randomizations for Average Risk Medulloblastoma: A Planned Analysis of Children’s Oncology Group (COG) ACNS0331

17. Favorable Chemotherapy Response is Associated With Improved Outcomes in Metastatic Atypical Teraroid/Rhabdoid Tumor (AT/RT) and May Permit Radiotherapy De-escalation Strategies: A Combined Analysis of Published Studies

19. International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma

20. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

21. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

22. MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children’s Oncology Group ACNS0332 Trial

25. Oryzatensin-stimulated PBMCs Increase Cancer Progression In-vitro

26. Molecular identification and characterization of Cryptosporidium spp. among pediatric and food-handlers subjects in Qatar

27. Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease

28. A Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT): A Children’s Oncology Group (COG) Study. Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors

30. Suicidal Ideation, Depression, and Aggression Among Students of Three Universities of Isfahan, Iran in 2008

32. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

33. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.

34. Cytogenetic prognostication within medulloblastoma subgroups

36. HG-106A NOVEL TOOL TO PREDICT THE SURVIVAL OF DIFFUSE INTRINSIC PONTINE GLIOMA PATIENTS: EXTERNAL VALIDATION OF THE SURVIVAL PREDICTION MODEL USING THE INTERNATIONAL DIPG REGISTRY

37. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

38. HG-14 * CLINICAL, RADIOGRAPHIC, AND HISTOLOGIC CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY

39. TR-14 * A FEASIBILITY AND RANDOMIZED PHASE II STUDY OF VORINOSTAT, BEVACIZUMAB, OR TEMOZOLOMIDE DURING RADIATION FOLLOWED BY MAINTENANCE CHEMOTHERAPY IN NEWLY-DIAGNOSED PEDIATRIC HIGH-GRADE GLIOMA: CHILDREN'S ONCOLOGY GROUP STUDY ACNS0822

40. MB-32 * FEASIBILITY OF VORINOSTAT COMBINED WITH ISOTRETINOIN AND CHEMOTHERAPY FOR YOUNG CHILDREN WITH NEWLY DIAGNOSED EMBRYONAL BRAIN TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY

41. BT-02 * FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA

42. TR-11 * A MOLECULAR BIOLOGY AND PHASE II STUDY OF IMETELSTAT (GRN163L) IN CHILDREN WITH RECURRENT OR REFRACTORY CENTRAL NERVOUS SYSTEM (CNS) MALIGNANCIES: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY

44. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma

45. A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study

46. CLINICAL TRIALS

47. MEDULLOBLASTOMA

48. HIGH GRADE GLIOMAS AND DIPG

49. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

50. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Catalog

Books, media, physical & digital resources